☆ 4.8 Article

Discovery of reactive peptide inhibitors of human papillomavirus oncoprotein E6

CHEMICAL SCIENCE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Biotechnology & Applied Microbiology

Drugging p53 in cancer: one protein, many targets

Ori Hassin et al.

Summary: Mutations in the TP53 gene are common in cancer, but restoring p53 functionality has been considered impossible for a long time. However, recent years have seen promising developments in p53-based therapy, including improved strategies and novel approaches. Small molecules that protect or restore p53 function are gaining interest, along with tailored drugs for specific p53 mutants. Additionally, gene therapy and immunotherapy are being reconsidered. However, significant challenges remain.

NATURE REVIEWS DRUG DISCOVERY (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and HumansS

Heather Eng et al.

Summary: This study investigated the metabolism of nirmatrelvir, a drug used to treat COVID-19, in animals and human reagents. The results showed moderate plasma clearance and bioavailability in rats and monkeys. Nirmatrelvir's metabolism was similar in liver microsomes and hepatocytes from rats, monkeys, and humans, and was primarily mediated by the enzyme CYP3A4. Additionally, nirmatrelvir was found to inhibit CYP3A activity.

DRUG METABOLISM AND DISPOSITION (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Molecular insights into the interaction of HPV-16 E6 variants against MAGI-1 PDZ1 domain

Lilian Esmeralda Araujo-Arcos et al.

Summary: The oncogenic protein E6 from Human Papilloma Virus 16 (HPV-16) degrades Membrane-associated guanylate kinase with inverted domain structure-1 (MAGI-1) by binding with its PDZ1 domain. Variations in the E6 gene can modify the interaction between E6 and MAGI-1. MAGI-1 is a scaffolding protein found at tight junctions of epithelial cells and regulates signaling pathways. Through computational simulations and protein-protein docking, we found that specific variants have increased affinity to MAGI-1.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Review Microbiology

Human papillomaviruses: diversity, infection and host interactions

Alison A. McBride

Summary: HPVs are a diverse group of viruses that replicate in specific anatomical niches of the stratified epithelia. Most infections are asymptomatic, but some can cause benign proliferative lesions or even cancer. These viruses have evolved to evade the host immune system and manipulate cellular processes to ensure their survival and replication.

NATURE REVIEWS MICROBIOLOGY (2022)

添加到收藏夹

Review Oncology

Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021

Qing Wu et al.

Summary: The US FDA has been at the forefront of drug evaluation and supervision. Over the past 31 years, 1050 drugs have been approved, with 228 of them being cancer therapeutics or cancer-related drugs. These drugs have evolved from broad-spectrum antitumor small molecules to more precise monoclonal antibodies and antibody-drug conjugates. However, the development of antitumor drugs is still limited by the available targets, mainly receptor tyrosine kinases.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Peptide-based covalent inhibitors of protein-protein interactions

Felix M. Paulussen et al.

Summary: Protein-protein interactions play a role in cellular processes and are potential therapeutic targets. However, identifying small molecular inhibitors for these interactions is challenging due to the often large and flat interaction areas. Peptide interaction motifs can serve as starting points for inhibitor development, and irreversible peptide-based ligands have gained attention in recent years.

JOURNAL OF PEPTIDE SCIENCE (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Advances in covalent drug discovery

Lydia Boike et al.

Summary: Covalent drugs have been widely used for over a century, but recent advances in tools for rational design have led to the successful development of potent and selective inhibitors, such as KRAS(G12C) inhibitors. The use of electrophile-first approaches and the emergence of chemoproteomics platforms have greatly enhanced the discovery and development of covalent drugs.

NATURE REVIEWS DRUG DISCOVERY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Binary combinatorial scanning reveals potent poly-alanine-substituted inhibitors of protein-protein interactions

Xiyun Ye et al.

Summary: Alanine substitution in peptides is crucial for studying peptide-based inhibitors of protein-protein interactions, but limited information is obtained from single alanine substitution. Here, the authors develop a label-free combinatorial alanine affinity selection platform to establish multi-alanine mutational tolerance and provide structure-activity relationships.

COMMUNICATIONS CHEMISTRY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Covalent peptides and proteins for therapeutics

Viktoriya Y. Berdan et al.

Summary: Drugs with a covalent mechanism of action have advantages in potency, selectivity, and in vivo efficacy. While traditionally limited to small molecules, recent advancements in peptide and protein therapeutics have allowed for the targeting of previously undruggable proteins and protein-protein interactions using covalent mechanisms.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

HPV16 E6 seropositivity and oropharyngeal cancer: Marker of exposure, risk, or disease?

Rebecca Landy et al.

EBIOMEDICINE (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Trends in peptide drug discovery

Markus Muttenthaler et al.

Summary: This Perspective summarizes key trends in peptide drug discovery and development, including human hormones, elegant medicinal chemistry and rational design strategies, peptide drugs derived from nature, and major breakthroughs in molecular biology and peptide chemistry. It also emphasizes lessons from earlier approaches that are still relevant today and discusses emerging strategies impact on peptide drug discovery.

NATURE REVIEWS DRUG DISCOVERY (2021)

添加到收藏夹

Article Immunology

A novel intracellular nanobody against HPV16 E6 oncoprotein

Wei Zhang et al.

Summary: The study demonstrated that the nanobody Nb9 targeting HPV16 E6 protein has high affinity and specificity, effectively inhibiting the function of HPV16 E6 in cells, enhancing apoptosis, and suppressing tumor growth. This presents a new possibility for the treatment of HPV-associated diseases.

CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Review Chemistry, Multidisciplinary

Biomedical Applications of a Novel Class of High-Affinity Peptides

Phei Er Saw et al.

Summary: Traditional therapeutic peptides have limitations, leading to the development of novel cyclic peptides with high affinity and specificity. The aptide platform offers advantages over ordinary linear peptides in terms of binding ability and specificity. Aptides show potential in biomedical applications, including imaging, therapy, and theranostics, by targeting specific disease-associated protein antigens.

ACCOUNTS OF CHEMICAL RESEARCH (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification of Secondary Binding Sites on Protein Surfaces for Rational Elaboration of Synthetic Protein Mimics

Justin M. Torner et al.

Summary: Minimal mimics of protein conformations designed as ligands can modulate protein function, but minimization may result in loss of affinity and specificity. Overcoming this challenge may involve using covalent warheads and nonnatural residues to improve contact with binding surfaces.

ACS CHEMICAL BIOLOGY (2021)

添加到收藏夹

Article Cell Biology

Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells

Jinshun Zhu et al.

Summary: This study identified three novel HPV16 E6-binding affibody molecules, which showed high binding affinity and specificity for HPV16 E6, selectively reducing the viability and proliferation of HPV16-positive cells. The combination of these affibody molecules with another targeting HPV16 E7 resulted in a more potent inhibition of cell proliferation, primarily through the induction of cell apoptosis and senescence. These findings suggest a potential rational strategy for molecular imaging and targeted therapy in HPV16-positive preneoplastic and neoplastic lesions.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Review Microbiology

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy

Asmita Pal et al.

FRONTIERS IN MICROBIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of E3 ligase E6AP with a proteasome-binding site provided by substrate receptor hRpn10

Gwen R. Buel et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Human Papillomavirus 16-Transgenic Mice as a Model to Study Cancer-Associated Cachexia

Sara Peixoto da Silva et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Chemistry, Medicinal

Is viral E6 oncoprotein a viable target? A critical analysis in the context of cervical cancer

Avinash Kumar et al.

MEDICINAL RESEARCH REVIEWS (2020)

添加到收藏夹

Article Medicine, General & Internal

Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank

Nicole Brenner et al.

EBIOMEDICINE (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Activatable cell-penetrating peptides: 15 years of research

Heleen de Jong et al.

RSC CHEMICAL BIOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants

Fabian Offensperger et al.

CELL CHEMICAL BIOLOGY (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Advances in covalent kinase inhibitors

Ayah Abdeldayem et al.

CHEMICAL SOCIETY REVIEWS (2020)

添加到收藏夹

Review Cell Biology

The multiple mechanisms that regulate p53 activity and cell fate

Antonina Hafner et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

添加到收藏夹

Article Neurosciences

Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome

Rossella Avagliano Trezza et al.

NATURE NEUROSCIENCE (2019)

添加到收藏夹

Review Medicine, General & Internal

Cervical cancer

Paul A. Cohen et al.

LANCET (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Synthesis of modified proteins via functionalization of dehydroalanine

Jitka Dadova et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2018)

添加到收藏夹

Article Chemistry, Medicinal

Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins

Aline D. de Araujo et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets

Karin Hoppe-Seyler et al.

TRENDS IN MICROBIOLOGY (2018)

添加到收藏夹

Article Chemistry, Multidisciplinary

Machine Learning To Predict Cell-Penetrating Peptides for Antisense Delivery

Justin M. Wolfe et al.

ACS CENTRAL SCIENCE (2018)

添加到收藏夹

Review Oncology

Opportunities and challenges for human papillomavirus vaccination in cancer

Richard B. S. Roden et al.

NATURE REVIEWS CANCER (2018)

添加到收藏夹

Review Obstetrics & Gynecology

Cervical cancer control in HIV-infected women: Past, present and future

Rahel G. Ghebre et al.

GYNECOLOGIC ONCOLOGY REPORTS (2017)

添加到收藏夹

Article Chemistry, Multidisciplinary

Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles

Tsukasa Sugo et al.

JOURNAL OF CONTROLLED RELEASE (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53

Denise Martinez-Zapien et al.

NATURE (2016)

添加到收藏夹

Article Cell Biology

Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV+ cells

C-H Yuan et al.

CELL DEATH & DISEASE (2016)

添加到收藏夹

Article Medicine, General & Internal

Carcinogenic human papillomavirus infection

Mark Schiffman et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

添加到收藏夹

Article Chemistry, Multidisciplinary

Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand

Juan Ramirez et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)

添加到收藏夹

Review Medical Laboratory Technology

Mechanisms of p53 degradation

Chuck C. -K. Chao

CLINICA CHIMICA ACTA (2015)

添加到收藏夹

Review Pharmacology & Pharmacy

Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies

Renato A. Bauer

DRUG DISCOVERY TODAY (2015)

添加到收藏夹

Review Biochemistry & Molecular Biology

From microbiology to cancer biology: the Rid protein family prevents cellular damage caused by endogenously generated reactive nitrogen species

Diana M. Downs et al.

MOLECULAR MICROBIOLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides

Christina Stutz et al.

PLOS ONE (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification and Characterization of Small Molecule Human Papillomavirus E6 Inhibitors

Kimberly A. Malecka et al.

ACS CHEMICAL BIOLOGY (2014)

添加到收藏夹

Article Chemistry, Medicinal

Drug discovery considerations in the development of covalent inhibitors

Robert Mah et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of a Potent Stapled Helix Peptide That Binds to the 70N Domain of Replication Protein A

Andreas O. Frank et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

The E6AP Binding Pocket of the HPV16 E6 Oncoprotein Provides a Docking Site for a Small Inhibitory Peptide Unrelated to E6AP, Indicating Druggability of E6

Katia Zanier et al.

PLOS ONE (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Structure Based Identification and Characterization of Flavonoids That Disrupt Human Papillomavirus-16 E6 Function

Jonathan J. Cherry et al.

PLOS ONE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Structural Basis for Hijacking of Cellular LxxLL Motifs by Papillomavirus E6 Oncoproteins

Katia Zanier et al.

SCIENCE (2013)

添加到收藏夹

Review Immunology

Comprehensive Control of Human Papillomavirus Infections and Related Diseases

F. Xavier Bosch et al.

VACCINE (2013)

添加到收藏夹

Article Virology

Peptide Interactions Stabilize and Restructure Human Papillomavirus Type 16 E6 To Interact with p53

Tina Ansari et al.

JOURNAL OF VIROLOGY (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses

Elizabeth A. White et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

添加到收藏夹

Article Biochemistry & Molecular Biology

Natural Product-Like Macrocyclic N-Methyl-Peptide Inhibitors against a Ubiquitin Ligase Uncovered from a Ribosome-Expressed De Novo Library

Yusuke Yamagishi et al.

CHEMISTRY & BIOLOGY (2011)

添加到收藏夹

Article Chemistry, Multidisciplinary

Methods for converting cysteine to dehydroalanine on peptides and proteins

Justin M. Chalker et al.

CHEMICAL SCIENCE (2011)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Highly potent and specific siRNAs against E6 or E7 genes of HPV16-or HPV18-infected cervical cancers

J. T-C Chang et al.

CANCER GENE THERAPY (2010)

添加到收藏夹

Review Microbiology

Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies

Sheila V. Graham

FUTURE MICROBIOLOGY (2010)

添加到收藏夹

Review Oncology

Human papillomavirus oncoproteins: pathways to transformation

Cary A. Moody et al.

NATURE REVIEWS CANCER (2010)

添加到收藏夹

Review Pathology

Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment

Sara I. Pai et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)

添加到收藏夹

Article Genetics & Heredity

A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein

Susanne Dymalla et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2009)

添加到收藏夹

Review Virology

Papillomavirus E6 proteins

Heather L. Howie et al.

VIROLOGY (2009)

添加到收藏夹

Article Biotechnology & Applied Microbiology

New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer

K. Yamato et al.

CANCER GENE THERAPY (2008)

添加到收藏夹

Article Oncology

Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo

XY Niu et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)

添加到收藏夹

Article Biochemistry & Molecular Biology

Design and characterization of helical peptides that inhibit the E6 protein of papillornavirus

YQ Liu et al.

BIOCHEMISTRY (2004)

添加到收藏夹

Article Biochemistry & Molecular Biology

Domain substructure of HPV E6 oncoprotein:: Biophysical characterization of the E6 C-terminal DNA-binding domain

Y Nominé et al.

BIOCHEMISTRY (2003)

添加到收藏夹

Article Pharmacology & Pharmacy

Elucidation of HIV-1 protease resistance by characterization of interaction kinetics between inhibitors and enzyme variants

CF Shuman et al.

ANTIVIRAL RESEARCH (2003)

添加到收藏夹

Article Biochemistry & Molecular Biology

Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP

XB Be et al.

BIOCHEMISTRY (2001)

添加到收藏夹

Article Multidisciplinary Sciences

Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator

L Ko et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.